{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18456255", "DateCompleted": {"Year": "2008", "Month": "08", "Day": "25"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2008", "Month": "04", "Day": "01"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ejphar.2008.03.036"], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "587", "Issue": "1-3", "PubDate": {"Year": "2008", "Month": "Jun", "Day": "10"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Interferon-alpha enhances artemisinin-induced differentiation of HL-60 leukemia cells via a PKC alpha/ERK pathway.", "Pagination": {"StartPage": "65", "EndPage": "72", "MedlinePgn": "65-72"}, "Abstract": {"AbstractText": ["Interferon-alpha (IFN-alpha) has been used in the treatment of several cancers, including chronic myeloid leukemia. Artemisinin, a sesquiterpene lactone endoperoxide that exists in several medicinal plants, is a well known anti-malarial agent. We previously reported that artemisinin by itself caused a relatively low level of HL-60 cell differentiation. In this study, we investigated the effects of IFN-alpha in combination with artemisinin on cell growth and differentiation in HL-60 leukemia cells. Combination of IFN-alpha and artemisinin synergistically induced the levels of leukemia cell differentiation, although IFN-alpha by itself did not affect cell proliferation and differentiation. The increased cell differentiation by IFN-alpha and artemisinin was significantly suppressed by the inhibitors for protein kinase C (PKC), extracellular signal-regulated kinase (ERK) and jun N-terminal kinase (JNK), but not by the inhibitors for phosphatidylinositol 3-kinase (PI3-K) and p38 mitogen-activated protein kinase (MAPK). Furthermore, co-treatment with IFN-alpha increased levels of PKC alpha and phosphorylated ERK. Taken together, these results indicate the enhancement of artemisinin-induced HL-60 cell differentiation by IFN-alpha through the activation of a PKC alpha/ERK signaling pathway, and suggest a possible use of IFN-alpha and artemisinin in the treatment of leukemic diseases."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Republic of Korea."}], "Identifier": [], "LastName": "Kim", "ForeName": "Seung Hyun", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chun", "ForeName": "Sang-Young", "Initials": "SY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Tae Sung", "Initials": "TS"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Artemisinins"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Interferon-alpha"}, {"RegistryNumber": "9RMU91N5K2", "NameOfSubstance": "artemisinin"}, {"RegistryNumber": "EC 1.2.1.-", "NameOfSubstance": "Glyceraldehyde-3-Phosphate Dehydrogenases"}, {"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "Protein Kinase C-alpha"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "Extracellular Signal-Regulated MAP Kinases"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "JNK Mitogen-Activated Protein Kinases"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Artemisinins"}, {"QualifierName": [], "DescriptorName": "Blotting, Western"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Differentiation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["antagonists & inhibitors", "physiology"], "DescriptorName": "Extracellular Signal-Regulated MAP Kinases"}, {"QualifierName": [], "DescriptorName": "Fluorescent Antibody Technique"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glyceraldehyde-3-Phosphate Dehydrogenases"}, {"QualifierName": [], "DescriptorName": "HL-60 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Interferon-alpha"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "JNK Mitogen-Activated Protein Kinases"}, {"QualifierName": ["antagonists & inhibitors", "physiology"], "DescriptorName": "Protein Kinase C-alpha"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "7", "Day": "11"}, {"Year": "2008", "Month": "3", "Day": "4"}, {"Year": "2008", "Month": "3", "Day": "14"}, {"Year": "2008", "Month": "5", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "8", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "5", "Day": "6", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18456255", "10.1016/j.ejphar.2008.03.036", "S0014-2999(08)00364-6"]}}], "PubmedBookArticle": []}